Category Archives: leadership

Merck CEO Outlines Next Two Years as IFPMA President, Raises Ire on IP

Merck KGaA CEO Stefan Oschmann spoke last week in New York as he accepted the two-year role as president of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the R&D industry’s global trade group based in Geneva.
Also posted in Global, Strategy | Tagged , , , , , , , | Leave a comment

Sparks Fly at Prix Galien Forum on US Health Reform

Last week’s Prix Galien Forum on global issues in life sciences was not without controversy. The absence of to be ousted Sanofi chief Christopher Viehbacher loomed over the event and notably on the day’s most contentious panel on US Healthcare Reform. Standing in for Viehbacher on the panel was Elias Zerhouni, President, Global R&D for […]
Also posted in Events, Strategy | Leave a comment

The Pharma Leadership Challenge: Thawing the “Frozen” Middle Managers

The challenge for senior leadership is to enable the layers of middle management to work to their full potential. Mike Straw argues that ‘failing fast’ should become the new mantra if pharma is going to drive greater innovation and creativity. J. Michael Pearson, CEO of Valeant, the Canadian based speciality drugmaker, recently said that “the […]
Also posted in Guest Blog, Strategy | Tagged , , | 1 Comment

Viehbacher Exits Sanofi

Christopher A. Viehbacher resigned as director of Sanofi immediately after its Board of Directors unanimously agreed to remove him as the company’s CEO yesterday. Chairman Serge Weinberg will replace Viehbacher on an interim basis.
Also posted in Europe, Global, Strategy | Tagged , | Leave a comment

Q&A: WebMD Chief David Schlanger

David Schlanger became WebMD’s CEO in August of 2013, but first joined the company in 1995, after serving as executive director, business development at Merck. The commercialization of pharmaceutical drugs has changed a lot in two decades: industry’s focus on specialty drugs for smaller populations and patients with chronic disease has supplanted the emphasis on […]
Also posted in Strategy | Tagged , | Leave a comment
  • Categories

  • Meta